| Trial ID: | L3433 |
| Source ID: | NCT01542463
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir
|
| Outcome Measures: |
Primary: HbA1c (glycaemic haemoglobin)|Fasting plasma glucose (FBG) | Secondary: Body weight change|Adverse drug reactions (ADR)|Serious adverse drug reactions (SADR)|Hypoglycaemic episodes
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
4464
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2004-09
|
| Completion Date: |
2007-07
|
| Results First Posted: |
|
| Last Update Posted: |
2016-03-03
|
| Locations: |
Mainz, 55127, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01542463
|
